Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer

BACKGROUND: The aim of this study is to evaluate a new tumour marker, HE4, and to compare it with CA125 in predicting optimal cytoreduction and response to chemotherapy. Thirty patients with advanced epithelial ovarian cancer and multiple sera harvested during neoadjuvant chemotherapy (NAC) were inc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Ovarian Res
Päätekijät: Pelissier, Aurélie, Roulot, Aurélie, Guéry, Béatrice, Bonneau, Claire, Bellet, Dominique, Rouzier, Roman
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5039904/
https://ncbi.nlm.nih.gov/pubmed/27677313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0270-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia